A short course of gabapentin for symptomatic radiculopathy secondary to lumbar disc herniation has demonstrated evidence of significant symptom improvement compared to placebo treatment.

Disclaimer:  While every attempt is made to ensure that drug dosages provided within the text of this journal and the website are accurate, readers are urged to check drug package inserts before prescribing. Views and opinions in this publication and the website are not necessarily endorsed by or reflective of those of the publisher.